We are live on ! Find out more
MRVI icon

Maravai LifeSciences

216 hedge funds and large institutions have $3.72B invested in Maravai LifeSciences in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 92 increasing their positions, 76 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $6.21M | Put options by funds: $2.65M

21% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 76

2.41% more ownership

Funds ownership: 97.31%99.72% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 235216 (-19)

17% less capital invested

Capital invested by funds: $4.51B → $3.72B (-$789M)

41% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 39

Holders
216
Holders Change
-19
Holders Change %
-8.09%
% of All Funds
3.64%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
92
Reduced
76
Closed
39
Calls
$6.21M
Puts
$2.65M
Net Calls
+$3.56M
Net Calls Change
-$7.32M
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
76
Fred Alger Management
New York
$2.62M +$329K +10,396 +13%
SAM
77
Sectoral Asset Management
Quebec, Canada
$2.54M +$135K +4,250 +5%
CAM
78
ClariVest Asset Management
California
$2.52M -$744K -23,500 -21%
State Board of Administration of Florida Retirement System
79
State Board of Administration of Florida Retirement System
Florida
$2.44M +$61.5K +1,943 +2%
SG Americas Securities
80
SG Americas Securities
New York
$2.42M +$2.61M +82,360 +2,878%
Los Angeles Capital Management
81
Los Angeles Capital Management
California
$2.3M -$1.05M -33,103 -29%
PA
82
Pinnacle Associates
New York
$2.16M -$78.1K -2,465 -3%
Capital Fund Management (CFM)
83
Capital Fund Management (CFM)
France
$2.13M +$1.44M +45,433 +154%
State of New Jersey Common Pension Fund D
84
State of New Jersey Common Pension Fund D
New Jersey
$1.98M -$187K -5,908 -8%
B
85
Bailard
California
$1.94M +$65.3K +2,060 +3%
PG
86
Pendal Group
Australia
$1.88M +$382K +12,073 +22%
Aviva
87
Aviva
United Kingdom
$1.83M +$2.05M +64,565 New
Allianz Asset Management
88
Allianz Asset Management
Germany
$1.83M +$750K +23,677 +58%
AG
89
Algert Global
California
$1.8M +$110K +3,479 +6%
PMAM
90
Picton Mahoney Asset Management
Ontario, Canada
$1.76M +$1.77K +56 +0.1%
Ohio Public Employees Retirement System (OPERS)
91
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.55M -$74.7K -2,358 -4%
Ameriprise
92
Ameriprise
Minnesota
$1.53M -$1.56M -49,151 -48%
Treasurer of the State of North Carolina
93
Treasurer of the State of North Carolina
North Carolina
$1.5M +$393K +12,407 +31%
US Bancorp
94
US Bancorp
Minnesota
$1.5M +$1.66M +52,555 +52,035%
ECM
95
ExodusPoint Capital Management
New York
$1.48M -$1.33M -41,840 -45%
RC
96
Renaissance Capital
Connecticut
$1.41M +$480K +15,145 +44%
Franklin Resources
97
Franklin Resources
California
$1.39M +$77.3K +2,441 +5%
Envestnet Asset Management
98
Envestnet Asset Management
Illinois
$1.39M +$712K +22,472 +85%
Royal Bank of Canada
99
Royal Bank of Canada
Ontario, Canada
$1.39M -$113K -3,575 -7%
TD Asset Management
100
TD Asset Management
Ontario, Canada
$1.36M -$1.06M -33,400 -41%

MRVI Hedge Fund Activity: Q2 2022 in Review

216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q2 2022, worth a combined $3.72B — down 17% from $4.51B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MRVI and 23 opened new positions — a net loss of 16 holders — while 76 trimmed existing stakes and 92 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $118M. The largest seller was Fidelity Investments, cutting an estimated $172M.

  • 216 institutional investors held Maravai LifeSciences (MRVI) as of Q2 2022, down from 235 in Q1 2022.
  • Funds reported $3.72B of Maravai LifeSciences stock for Q2 2022, down 17% quarter-over-quarter.
  • 23 funds opened new Maravai LifeSciences positions in Q2 2022 and 39 closed out, a net change of -16 holders.
  • The largest Maravai LifeSciences buyer in Q2 2022 was Massachusetts Financial Services, an estimated $118M added.
  • The largest Maravai LifeSciences seller in Q2 2022 was Fidelity Investments, an estimated $172M sold.

Based on aggregated 13F filings for Q2 2022.